X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/camurus-announces-new-phase-3-data-reinforcing-long-term-safety-and-efficacy-of-octreotide-sc-depot-cam2029-in-patients-with-acromegaly-301878210.html
https://www.prnewswire.com/news-releases/camurus-announces-fda-approval-of-brixadi-for-the-treatment-of-moderate-to-severe-opioid-use-disorder-301832957.html
https://www.prnewswire.com/news-releases/camurus-announces-pdufa-date-for-brixadi-for-the-treatment-of-opioid-use-disorder-in-the-us-301320571.html
https://www.prnewswire.com/news-releases/camurus-announces-braeburn-resubmits-new-drug-application-for-brixadi-in-the-us-301313174.html
https://www.prnewswire.com/news-releases/camurus-announces-braeburn-resubmits-new-drug-application-for-brixadi-in-the-us-301313174.html
https://www.prnewswire.com/news-releases/camurus-announces-publication-showing-superior-patient-treatment-satisfaction-with-buvidal-weekly-and-monthly-depot-injections-in-opioid-dependence-301287635.html
https://www.prnewswire.com/news-releases/the-australian-tga-approves-key-label-updates-to-buvidal-for-treatment-of-opioid-dependence-301281919.html
https://www.pmcpa.org.uk/about-us/media/news/camurus-accord-swedish-orphan-biovitrum-sobi-strides-pharma-boehringer-ingelheim-vifor-pharma-glaxosmithkline-and-sintetica-named-in-advertisements-for-breaches-of-the-abpi-code/
https://www.prnewswire.com/news-releases/camurus-announces-submission-of-request-for-final-approval-of-brixadi-for-the-treatment-of-opioid-use-disorder-in-the-us-301068822.html
Market Place
Share 
